Med. praxi. 2013;10(3):97-103 [Prakt. lékáren. 2012; 8(5): 207-212]

Asthma treatment - mistakes and errors in daily practice

doc.MUDr.Milan Teřl, Ph.D.
Klinika TRN, FN a LF UK v Plzni

The majority of patients with asthma can be relatively easily treatead thanks to availibility of highly effective medications. In the reality,

however, more than 50 % of asthmatic patients remains with poorly controlled disease, 1/3 of them have severe troubles. The most

common cause of asthma mediactions not working is that the patiens are not adherent to prescribed therapy. Our challenges are to be

sure that patients understand the principles of asthma management and use their inhalational drugs correctly. This article reviews and

discusses the current available therapy and summarizes for clinical settings.

Keywords: asthma, therapy, inhalation therapy

Published: March 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teřl M. Asthma treatment - mistakes and errors in daily practice. Med. praxi. 2013;10(3):97-103.
Download citation

References

  1. Teřl M, Pohunek P, et al. (eds). Strategie diagnostiky, prevence a léčby astmatu. Praha, ČIPA, Jalna, 2012: 90.
  2. Kašák V. Astma bronchiale. Praha, Jessenius/Maxdorf, 2005: 148 (72-76, 80).
  3. Sims MW. Aerosol therapy for obstructive lung diseases: device selection and practice management issues. Chest. 2011; 140(3): 781-788. Go to original source... Go to PubMed...
  4. Lee-Woong M, Mayo PH. Results of a programme to improve house staff use of metered dose inhalers and spacers. Postgrad Med J. 2003; 79: 221-225. Go to original source... Go to PubMed...
  5. Teřl M. Pohled na astma prizmatem eozinofilie a alergie. Stud Pneumol. Phtiseol. 2009; 69(4): 130-139.
  6. Feketeová E, Kašák V, Pohunek P, Špičák V. Inhalační systémy. Mediforum, Maxdorf 2004.
  7. Bystroň J. Léčba alergických onemocnění. Praktické lékárenství 2011; 7(2): 63-67.
  8. Barnes PJ. Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol. 2012; 129(1): 48-59. Go to original source... Go to PubMed...
  9. Kašák V. Nové inhalační systémy užívané v léčbě chronických nemocí dýchacího ústrojí s obstrukcí dýchacích cest. Remedia 2007; 1: 26-38.
  10. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implicationss. Allergy 2008; 63(10): 1292-300. Go to original source... Go to PubMed...
  11. Kašák V. Ciclesonid. Farmakoterapie 2006; 2: 21-28.
  12. Teřl M. Moderní terapie perzistujícího bronchiálního astmatu. Acta medicinae 2012; 3: 70-72.
  13. Amlani S, Nadarajah T, McIvor RA. Montelukast for the treatment of asthma in the adult population. Expert Opin Pharmacother. 2011; 12(13): 2119-2128. Go to original source... Go to PubMed...
  14. Colice GL. Emerging therapeutic options for asthma. Am J Manag Care. 2011; 17(Suppl 3): S82-89. Go to PubMed...
  15. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med. 2006; 173(9): 965-969. Go to original source... Go to PubMed...
  16. Peters SP, Kunselman SJ, Iciovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. NEJM 2010; 363: 1715-1726. Go to original source... Go to PubMed...
  17. Barnes PJ. Theophylline for COPD. Thorax. 2006; 61(9): 742-744. Go to original source... Go to PubMed...
  18. Kašák V, Feketeová E, Špičák V. Analýza chybovosti v užívání inhalačních systémů v léčbě astmatu. Alergie 2004; 6(Suppl. 1): 42-48.
  19. Chapman KR, Voshaar TH, Virchow JC. Inhaler choice in primary care. Eur Respir Rev 2005; 14(96): 117-122. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.